Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...

It has seen a steady rise from $1.28 billion in 2024 to $1.36 billion in 2025, indicating a compound annual growth rate CAGR of 6.6%. The marked growth during the historic period can be attributed to ...

Market is Segmented by Type (Distributed BDU, Centralized BDU), by Application (BEV, PHEV). The Battery Disconnect Unit (BDU) Market was valued at USD 3657 Million in the year 2024 and is projected to ...

Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and bioconjugates, has announced today the formation of its Scientific Advisory Board (SAB) comprised of biopharma industry ...

In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man ...

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account ...

Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential ...

As per the latest analysis, the biosimilar and biologics market value is estimated to reach USD 520.9 billion in 2024. Global sales of biosimilars and biologics will likely increase at 7.6% CAGR ...

Shares of Eli Lilly & Co. LLY advanced 2.48% to $733.29 Thursday, on what proved to be an all-around great trading session ...

The global breast cancer drug market continues to gain momentum, fueled by increasing awareness, technological innovation, and advancements in personalized medicine. According to the latest industry ...

Carrie Mckim; Investor Relations; Codexis Inc. Stephen Dilly; Chairman of the Board, President, Chief Executive Officer, Director; Codexis Inc. Stefan Lutz; Senior V ...

Universal Health Services Inc. Cl B $194.15 6.32 3.36% ...